Gene News and Research

Latest Gene News and Research

Scientists find seven new genes that can cause X-linked intellectual disability

Scientists find seven new genes that can cause X-linked intellectual disability

Researcher uses Gene Rank technique to capture, describe gene connectivity

Researcher uses Gene Rank technique to capture, describe gene connectivity

Researchers identify two cell-signaling molecules that appear critical to stalling cancer's spread

Researchers identify two cell-signaling molecules that appear critical to stalling cancer's spread

A*STAR's GIS scientists develop new system that can predict treatment targets for cancer

A*STAR's GIS scientists develop new system that can predict treatment targets for cancer

Novel image-analysis technique improves breast cancer detection and diagnosis

Novel image-analysis technique improves breast cancer detection and diagnosis

Immune system exploits flu virus' dependence on host's machinery

Immune system exploits flu virus' dependence on host's machinery

Researchers identify RGS6 protein that controls both alcohol-seeking behavior and organ damage

Researchers identify RGS6 protein that controls both alcohol-seeking behavior and organ damage

Researchers identify molecular pathways associated with distinct subsets of SSc patients

Researchers identify molecular pathways associated with distinct subsets of SSc patients

Rare and classic EGFR mutations have different impacts on NSCLC outcome

Rare and classic EGFR mutations have different impacts on NSCLC outcome

Children exposed to air pollution are at increased risk for brain inflammation, neurodegenerative changes

Children exposed to air pollution are at increased risk for brain inflammation, neurodegenerative changes

Oral pathogen protects different tumor cells from being killed by immune cells

Oral pathogen protects different tumor cells from being killed by immune cells

FDA advisory committees to review Amgen's talimogene laherparepvec for metastatic melanoma treatment

FDA advisory committees to review Amgen's talimogene laherparepvec for metastatic melanoma treatment

Movement Disorder Center at UC San Diego designated Center of Excellence in NPF's global network

Movement Disorder Center at UC San Diego designated Center of Excellence in NPF's global network

Freiburg researchers identify novel approach to inhibit signalling processes in colorectal cancer cells

Freiburg researchers identify novel approach to inhibit signalling processes in colorectal cancer cells

UNC researchers create new research tool to help crack the histone code

UNC researchers create new research tool to help crack the histone code

Leukemia & Lymphoma Society announces launch of new partnership to empower people with lymphoma

Leukemia & Lymphoma Society announces launch of new partnership to empower people with lymphoma

TAU researchers identify novel genetic mutation as source of specific rare disease

TAU researchers identify novel genetic mutation as source of specific rare disease

Researchers identify axitinib as promising candidate to treat drug-resistant leukaemia

Researchers identify axitinib as promising candidate to treat drug-resistant leukaemia

New research provides hope for treating stroke using HUCBCs

New research provides hope for treating stroke using HUCBCs

Japanese researchers explore use of bone marrow transplants to treat hypophosphatasia

Japanese researchers explore use of bone marrow transplants to treat hypophosphatasia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.